Sulfonamidomethyl phosphonate inhibitors of β-lactamase
US7030103B2 · kind B2 · utility
0Cited by
6References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 8, 2002 |
| Grant date | Apr 18, 2006 |
| Priority date | — |
| Expiry date | Oct 8, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/655345
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The intention relates to bacterial antibiotic resistance and, in particular, to compositions and methods for overcoming bacterial antibiotic resistance. The invention provides novel β-lactamase inhibitors, which are structurally unrelated to the natural product and semi-synthetic β-lactamase inhibitors presently available, and which do not require a β-lactam pharmacophore. The invention also provides pharmaceutical compositions and methods for inhibiting bacterial growth.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.